Aspergillosis differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 385: | Line 385: | ||
*[[Polymerase chain reaction|PCR]] of [[CSF]] for [[JC virus]] | *[[Polymerase chain reaction|PCR]] of [[CSF]] for [[JC virus]] | ||
*[[Biopsy]] reveals [[white matter]] [[lesions]] and not well-circumscribed [[lesions]]. | *[[Biopsy]] reveals [[white matter]] [[lesions]] and not well-circumscribed [[lesions]]. | ||
|} | |||
===Differentiating invasive aspergillosis from other diseases=== | |||
Invasive aspergillosis must be differentiated from other conditions with similar presentation. [[Invasive (medical)|Invasive]] fungal disease should be considered in any [[immunocompromised]] patient presenting with a new [[cranial]] [[neuropathy]] or [[ocular]] [[motility]] abnormality<ref name="pmid261128692">{{cite journal |vauthors=Trief D, Gray ST, Jakobiec FA, Durand ML, Fay A, Freitag SK, Lee NG, Lefebvre DR, Holbrook E, Bleier B, Sadow P, Rashid A, Chhabra N, Yoon MK |title=Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus |journal=Br J Ophthalmol |volume=100 |issue=2 |pages=184–8 |year=2016 |pmid=26112869 |doi=10.1136/bjophthalmol-2015-306945 |url=}}</ref> for example, [[mucormycosis]]. The differentials include: | |||
{| class="wikitable" | |||
! rowspan="2" |Disease | |||
! rowspan="2" |General features | |||
! colspan="3" |Signs and Symptoms | |||
! rowspan="2" |Radiological abnormalities | |||
! rowspan="2" |Histopathological abnormalities | |||
! rowspan="2" |Other differentiating characters | |||
|- | |||
|Facial/Sinus swelling and ulceration | |||
|Cranial neuropathy | |||
|Disturbance in ocular motility | |||
|- | |||
|Mucormycosis | |||
| | |||
* Agents found in: | |||
** decaying vegetation | |||
** Soil | |||
* Acquired by: | |||
** [[Inhalation]] | |||
** [[Ingestion]] | |||
** [[contamination]] of [[wounds]] with sporangiospores from the environment. | |||
** Air-conditioning systems, particularly during construction | |||
** Use of [[Contamination|contaminated]] adhesive bandages or tape in [[Surgical dressings|surgical wound dressings]] | |||
* Susceptible individuals: | |||
** [[Immunocompromised]] patients | |||
** [[Diabetics]] | |||
** Patients receiving [[deferoxamine]] therapy | |||
** Injection drug users | |||
** Patients with no apparent [[immune]] impairment | |||
* [[Invasive (medical)|Invasive]] mucormycosis is clinically similar to [[aspergillosis]] and is marked by angioinvasion and [[Tissue (biology)|tissue]] [[infarction]] | |||
| | |||
* + | |||
([[Mucosal]] thickening on the [[Paranasal sinus|paranasal sinuses]] is '''more common in rhinocerebral mucormycosis'''(ROCM) than bacterial [[orbital cellulitis]](BOC)<ref name="pmid275010443">{{cite journal |vauthors=Son JH, Lim HB, Lee SH, Yang JW, Lee SB |title=Early Differential Diagnosis of Rhino-Orbito-Cerebral Mucormycosis and Bacterial Orbital Cellulitis: Based on Computed Tomography Findings |journal=PLoS ONE |volume=11 |issue=8 |pages=e0160897 |year=2016 |pmid=27501044 |pmc=4976984 |doi=10.1371/journal.pone.0160897 |url=}}</ref> | |||
| | |||
* + | |||
(Specially if there is invasion of the [[cavernous sinus]]) | |||
| | |||
* + | |||
(Limited eye movement is '''more common in patients with rhino-cerebral mucormycosis (ROCM)''' than in those with bacterial [[orbital cellulitis]])<ref name="pmid275010442">{{cite journal |vauthors=Son JH, Lim HB, Lee SH, Yang JW, Lee SB |title=Early Differential Diagnosis of Rhino-Orbito-Cerebral Mucormycosis and Bacterial Orbital Cellulitis: Based on Computed Tomography Findings |journal=PLoS ONE |volume=11 |issue=8 |pages=e0160897 |year=2016 |pmid=27501044 |pmc=4976984 |doi=10.1371/journal.pone.0160897 |url=}}</ref> | |||
| | |||
* CT scan: | |||
** Reverse halo sign (characterized by central [[Ground glass opacification on CT|ground-glass opacity]] ([[Ground glass opacification on CT|GGO]]) which is surrounded by a partial or complete rim of [[Consolidation (medicine)|consolidation]])<ref /> is more common in patients with [[pulmonary]] mucormycosis than in those with [[Invasive aspergillosis|invasive pulmonary aspergillosis]]<ref /> | |||
| | |||
* Nonpigmented, wide (5- to 20-μm), thin-walled, ribbon-like [[hyphae]] with few [[Septate|septations]] (pauciseptate) and right-angle branching<ref name="pmid21482725">{{cite journal |vauthors=Guarner J, Brandt ME |title=Histopathologic diagnosis of fungal infections in the 21st century |journal=Clin. Microbiol. Rev. |volume=24 |issue=2 |pages=247–80 |year=2011 |pmid=21482725 |pmc=3122495 |doi=10.1128/CMR.00053-10 |url=}}</ref> | |||
* In [[Lesion|lesions]] exposed to air, thick-walled spherical structures can form at the ends of the [[hyphae]] | |||
* [[Fungal]] elements invading the [[blood vessel]] wall or inside their [[Lumen (anatomy)|lumen]] | |||
| | |||
* Mucormycosis is generally more commonly observed in [[immunocompromised]] patients | |||
* Patients with [[Orbital Disease|orbital]] [[fungal]] infections are more likely to be infected with mucormycosis compared with [[Aspergillus]]<ref name="pmid26112869">{{cite journal |vauthors=Trief D, Gray ST, Jakobiec FA, Durand ML, Fay A, Freitag SK, Lee NG, Lefebvre DR, Holbrook E, Bleier B, Sadow P, Rashid A, Chhabra N, Yoon MK |title=Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus |journal=Br J Ophthalmol |volume=100 |issue=2 |pages=184–8 |year=2016 |pmid=26112869 |doi=10.1136/bjophthalmol-2015-306945 |url=}}</ref> | |||
* The [[prognosis]] of [[pulmonary]] mucormycosis has not improved significantly over the last ten years<ref name="pmid22167397">{{cite journal |vauthors=Hamilos G, Samonis G, Kontoyiannis DP |title=Pulmonary mucormycosis |journal=Semin Respir Crit Care Med |volume=32 |issue=6 |pages=693–702 |year=2011 |pmid=22167397 |doi=10.1055/s-0031-1295717 |url=}}</ref> | |||
|- | |||
|[[Invasive aspergillosis]] | |||
| | |||
* [[Aspergillosis]] is a heterogenous group of [[Infectious disease|infectious diseases]] caused by ''[[Aspergillus]]''(commonly ''[[Aspergillosis|A. fumigatus]]'') | |||
* Classified into: | |||
** [[Allergic bronchopulmonary aspergillosis]] ([[Aspergillosis|ABPA]]) | |||
** [[Aspergilloma]] | |||
** [[Chronic pulmonary aspergillosis]] | |||
** [[Invasive aspergillosis]] | |||
** [[Cutaneous aspergillosis]] | |||
* Trasmitted by: | |||
** [[Inhalation]] of airborne [[conidia]] (usually during dust exposure during building renovation or construction) | |||
** [[Contamination|Contaminated]] biomedical devices, but not from one individual to another. | |||
* Susceptible individuals: | |||
** [[Immunocompromised]] status (e.g. organ or [[Stem cell transplant|stem cell transplant recipient]]) | |||
** History of prior [[lung]] disease | |||
| | |||
* + | |||
| | |||
* + | |||
| | |||
* + | |||
(There may be painful [[ophthalmoplegia]] if there is invasion of the [[cavernous sinus]])<ref name="pmid16459537">{{cite journal |vauthors=Siraj CA, Krishnan J, Nair RR, Girija AS |title=Invasive aspergillosis producing painful ophthalmoplegia |journal=J Assoc Physicians India |volume=53 |issue= |pages=901–2 |year=2005 |pmid=16459537 |doi= |url=}}</ref> | |||
| | |||
* CT scan: | |||
** Reverse halo sign | |||
** [[Allergic bronchopulmonary aspergillosis]] ([[ABPA]]) are not specific, the demonstration of [[bronchial]] [[Dilation|dilatation]], wall thickening, and centrilobular [[Nodule (medicine)|nodules]] in an [[asthmatic]] patient should suggest the [[diagnosis]] | |||
| | |||
* Microscopic observation under [[ultraviolet light]] shows that the [[hyphae]] of [[aspergillus]] have characteristic dichotomous branching, parallel walls, and numerous septa. These septa structure is clearly different from those of the [[mucor]] | |||
* Clusters of centrilobular [[Nodule (medicine)|nodules]], peribronchial [[Consolidation (medicine)|consolidations]], and [[Bronchial|bronchial wall]] thickening, are more common in patients with [[Invasive aspergillosis|invasive pulmonary aspergillosis]]<ref name="pmid258823622">{{cite journal |vauthors=Jung J, Kim MY, Lee HJ, Park YS, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH |title=Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis |journal=Clin. Microbiol. Infect. |volume=21 |issue=7 |pages=684.e11–8 |year=2015 |pmid=25882362 |doi=10.1016/j.cmi.2015.03.019 |url=}}</ref> | |||
| | |||
|- | |||
|[[Orbital cellulitis]] | |||
| | |||
* [[Orbital cellulitis]] is an [[inflammation]] of the soft tissues of the eye socket behind the [[orbital septum]], a thin tissue which divides the [[eyelid]] from the [[eye socket]] | |||
* [[Infection]] isolated [[anterior]] to the orbital septum is considered to be [[preseptal cellulitis]] | |||
* [[Orbital cellulitis]] most commonly refers to an [[Acute (medicine)|acute]] spread of [[infection]] into the [[eye socket]] from either the adjacent [[sinuses]], [[skin]] or from spread through the [[blood]] | |||
* The most common [[pathogens]] in [[orbital cellulitis]] are [[streptococcus]] and [[staphylococcus]] | |||
| | |||
* + | |||
| | |||
* + | |||
| | |||
* +<ref name="pmid22346113">{{cite journal |vauthors=Chaudhry IA, Al-Rashed W, Arat YO |title=The hot orbit: orbital cellulitis |journal=Middle East Afr J Ophthalmol |volume=19 |issue=1 |pages=34–42 |year=2012 |pmid=22346113 |pmc=3277022 |doi=10.4103/0974-9233.92114 |url=}}</ref> | |||
(The [[ocular]] [[Symptom|symptoms]] of bacterial [[orbital cellulitis]] ([[Orbital cellulitis|BOC]]) , such as facial [[edema]], [[pain]], and [[blepharoptosis]], are similar to those of rhino-cerebral mucormycosis (ROCM) soon after [[infection]] onset, therefore it maybe difficult to distinguish the two during the initial phase of infection. | |||
Eye lid [[swelling]] is '''more common in [[Orbital cellulitis|BOC]] than ROCM)'''<ref name="pmid27501044">{{cite journal |vauthors=Son JH, Lim HB, Lee SH, Yang JW, Lee SB |title=Early Differential Diagnosis of Rhino-Orbito-Cerebral Mucormycosis and Bacterial Orbital Cellulitis: Based on Computed Tomography Findings |journal=PLoS ONE |volume=11 |issue=8 |pages=e0160897 |year=2016 |pmid=27501044 |pmc=4976984 |doi=10.1371/journal.pone.0160897 |url=}}</ref> | |||
| | |||
* CT scan: | |||
** Cross-sectional imaging demonstrates [[diffuse]] [[soft-tissue]] thickening [[anterior]] to the [[orbital septum]] and obliteration of the adjacent [[fat]] planes in pre-septal cellulitis | |||
| | |||
* [[Biopsy]] may show a [[Neutrophilia|neutrophilic]] infiltration of the [[tissues]] due to [[Inflamation|acute inflammation]] | |||
| | |||
|- | |||
|Extra nodal T cell lymphoma | |||
| | |||
* These [[Tumor|tumors]] are more clearly classified as nasal-type extranodal [[T-cell lymphoma|T-cell/natural killer (T/NK) cell lymphoma]] and [[natural killer cell]] [[leukemia]] | |||
* [[Epstein Barr virus|Epstein bar virus]] ([[Epstein Barr virus|EBV]]) has been found to be one of the major causes. | |||
* They are characterized [[Immunophenotyping|immunophenotypically]] by the expression of [[CD2]], CD3ϵ (but not [[CD3 (immunology)|CD3]] and the [[T cell receptor|T-cell receptor]]), and [[CD56]]<ref name="pmid27178138">{{cite journal |vauthors=Zhang Y, Wang T, Liu GL, Li J, Gao SQ, Wan L |title=Mucormycosis or extranodal natural killer/T cell lymphoma, similar symptoms but different diagnosis |journal=J Mycol Med |volume=26 |issue=3 |pages=277–82 |year=2016 |pmid=27178138 |doi=10.1016/j.mycmed.2016.04.005 |url=}}</ref> | |||
* The [[lesion]] produced are destructive and involve the [[nasal cavity]], [[oropharynx]], [[Palate|upper palate]], and [[larynx]] | |||
* [[Immunophenotyping]] shows these lesions to be [[lymphoid]] in nature | |||
| | |||
* + | |||
| | |||
* +<ref name="pmid24419127">{{cite journal |vauthors=Prajapati HJ, Vincentelli C, Hwang SN, Voloschin A, Crocker I, Dehkharghani S |title=Primary CNS natural killer/T-cell lymphoma of the nasal type presenting in a woman: case report and review of the literature |journal=J. Clin. Oncol. |volume=32 |issue=8 |pages=e26–9 |year=2014 |pmid=24419127 |doi=10.1200/JCO.2012.47.6796 |url=}}</ref> | |||
(Primary [[CNS]] NK/[[T-cell lymphoma|Tcell lymphoma]] of the nasal type) | |||
| | |||
* +/- | |||
| | |||
* CT scan: | |||
** The [[Computed tomography|CT]] and [[Magnetic resonance imaging|MR]] imaging appearances are nonspecific and do not allow reliable distinction of this disease from other [[nasal cavity]] [[Tumor|tumors]] such as [[squamous cell carcinoma]] or from minor [[salivary gland]] [[tumor]]. | |||
| | |||
* “Angiocentric” invasion of [[Lymphoid cell|lymphoid cells]] is Angiocentricity is seen in about half of all cases but is also found in other [[lymphoma]] subtypes. | |||
* Invasion of [[vascular]] walls by [[lymphoid]] cells causes occlusion of the [[Lumen (anatomy)|lumen]]. | |||
* The [[vascular]] occlusion is usually associated with prominent [[ischemic necrosis]] of both [[Tumor cell|tumor cells]] and normal [[Tissue (biology)|tissue]]. | |||
| | |||
|- | |||
|[[Cutaneous anthrax|Cutaneous Anthrax]] | |||
| | |||
* [[Cutaneous anthrax]] is extremely rare in developed countries | |||
* Usually patient history points towards the [[diagnosis]] of [[cutaneous anthrax]] | |||
* Patient develops a painless [[ulcer]] with [[vesicles]], [[edema]], and has a history of exposure to animals or animal products<ref name="pmid9056659">{{cite journal |vauthors=Mallon E, McKee PH |title=Extraordinary case report: cutaneous anthrax |journal=Am J Dermatopathol |volume=19 |issue=1 |pages=79–82 |year=1997 |pmid=9056659 |doi= |url=}}</ref>; whereas patients with cutaneous mucormycosis are mainly debilitated ([[Diabetes mellitus|diabetics]], hematological [[malignancies]], [[organ transplant]] recepients) and present as a black [[Necrotic tissue|necrotic]] [[eschar]]<ref name="pmid23930354">{{cite journal |vauthors=Skiada A, Petrikkos G |title=Cutaneous mucormycosis |journal=Skinmed |volume=11 |issue=3 |pages=155–9; quiz 159–60 |year=2013 |pmid=23930354 |doi= |url=}}</ref> | |||
| | |||
* + | |||
| | |||
| | |||
| | |||
* Imaging modalities are not indicated in [[cutaneous anthrax]] | |||
| | |||
* [[Epithelium]] is [[Edema|edematous]] with loss of continuity. | |||
* Sub-epidermal, [[Chronic (medical)|chronic]] and [[Acute (medicine)|acute]] infiltrates involving [[adipose tissue]] and [[Capillary|capillaries]], with areas of [[necrosis]]. | |||
* [[Gram stain]] shows large solid and beaded [[gram-positive]] rods, particularly beneath the [[epithelium]]. | |||
* The [[bacilli]] are not visible on the [[H&E stain|hematoxylin and eosin stain]]. | |||
| | |||
|} | |} | ||
Revision as of 15:52, 14 August 2017
Aspergillosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Aspergillosis differential diagnosis On the Web |
American Roentgen Ray Society Images of Aspergillosis differential diagnosis |
Risk calculators and risk factors for Aspergillosis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Haytham Allaham, M.D. [2]; Serge Korjian M.D.
Overview
Aspergillosis must be differentiated from other diseases that cause fever, chest pain, dyspnea, sinusitis, allergic symptoms, and elevated IgE concentrations. Differential diagnosis includes other infections (fungi, bacteria, viruses, and parasites), non-infectious pulmonary diseases (such as asthma, COPD, interstitial lung disease, bronchiectasis, and lung tumors), cardiac diseases (such as pericarditis, endocarditis, or myocarditis), facial diseases (such as infectious sinusitis, sinus tumor, or nasal polyps), systemic diseases (such as Hyper IgE syndrome, Churg-Strauss syndrome, granulomatosis with polyangiitis, Goodpasture's syndrome), congenital diseases (such as cystic fibrosis or ciliary dyskinesia), transplant-related complications (such as GVHD), diseases with cutaneous manifestations (such as eczema, scabies, deep vein thrombosis, cellulitis), and adverse drug reactions.
Diffential Diagnosis
Aspergillosis must be differentiated from other diseases that cause fever, chest pain, dyspnea, sinusitis, allergic symptoms, and elevated IgE concentrations. Differential diagnosis includes:
- Actinomycosis
- Acute Respiratory Distress Syndrome
- Aspiration (e.g. foreign body)
- Asthma
- Arteriovenous malformation
- Blastomycosis
- Bronchiectasis and mucoid impaction
- Bronchocentric granulomatosis
- Cellulitis
- Churg-Strauss syndrome
- Coccidiomycosis
- COPD exacerbation
- Cryptococcosis
- Ciliary dyskinesia
- Cystic fibrosis
- Deep vein thrombosis
- Drug - adverse reaction
- Eczema
- Endocarditis
- Eosinophilia
- Eosinophilic pneumonia
- Goodpasture's syndrome
- Granulocytopenia
- Granulomatosis with polyangiitis (Wegener's granulomatosis)
- Graft vs. host disease
- Heart failure
- Hemosiderosis
- Hemothorax
- Histoplasmosis
- Histiocytosis
- Hypereosinophilic syndrome
- Hypersensitivity Pneumonitis
- Hyper IgE syndrome (Job's syndrome)
- Impetigo
- Infectious sinusitis
- Interstitial lung disease
- Leishmaniasis
- Leproma (leprosy nodule)
- Leukemia
- Loffler's syndrome
- Lung Abscess
- Lung tumor (primary or metastatic)
- Lymphoma
- Malaria
- Mucormycosis
- Myeloproliferative disorder
- Myocardial abscess
- Myocarditis
- Nasopharyngeal polyp
- Nocardiosis
- Paracoccidioidomycosis
- Pericarditis
- Pneumonia
- Pneumothorax
- Pulmonary embolism
- Pulmonary eosinophilia
- Pulmonary arterial hypertension
- Sarcoidosis
- Scabies
- Scedosporiosis (pulmonary infection caused by the fungus Scedosporium)
- Sporotrichosis
- Sinus tumor
- Trauma
- Tuberculosis (including tuberculoma)
- Zygomycosis
Pathogen | Disease | Geographic distribution | High risk Groups | Differentiating features | Microscopic findings | |
---|---|---|---|---|---|---|
Physical exam | Laboratory findings | |||||
Fungal | Histoplasmosis | Mississippi and Ohio River valleys |
|
|
|
Yeast are typically smaller, with narrow-based budding, found intracellularly within macrophages |
Coccidioidomycosis | Southwestern US region | Opportunistic infection seen in AIDS |
|
Serologic tests( enzyme immune assay )more sensitive | Characteristic spherule appearance | |
Paracoccidioidomycosis[3] | Central and South america | Opportunistic infection seen in AIDS |
|
|
Smaller fungi with thin cell walls, forming mariner wheel appearance, circumferentially surrounding the parent cell.( Captain wheel appearance ) | |
Sporotrichosis | Ubiquitous | Gardeners [4] |
|
+ Sporotrichin skin test | Finger or cigar shaped yeast. | |
Aspergillosis[5] | Ubiquitous |
|
Cell wall detection using galactomannan antigen detection, Beta-D-glucan detection test. | Septated hyphae with acute angle branching | ||
Bacterial | Anthrax | Ubiquitous | Live stock handlers |
|
|
Nonmotile, Gram-positive, aerobic or facultatively anaerobic, endospore-forming, rod-shaped bacterium |
Legionella | Ubiquitous | Chronic lung disease
Building water systems |
|
Gram negative bacterium | ||
Tuberculosis | Asia,Africa | Ill contact individuals |
|
Aerobic, non-encapsulated, non-motile, acid-fast bacillus | ||
Listeriosis | Ubiquitous | Pregnant women [8]
Adults > 65 |
|
|
flagellated, catalase-positive, facultative intracellular, anaerobic, nonsporulating, Gram-positive bacillus | |
Brucellosis |
Mexico, South and Central America |
People who take unpasteurized dairy products |
|
|
Gram-negative bacteria,non-motile, encapsulated coccobacilli. | |
Scrub typhus | Asia-Pacific region
Australia Afghanistan |
Hikers[9] |
|
a Gram-negative α-proteobacterium intracellular parasite | ||
Leptospirosis | Temperate, tropical climates. | People who work with animals |
|
Spiral-shaped bacteria with hooked ends on dark-field. | ||
Cat scratch fever | Ubiquitous | cat licking a person's open wound, or bites or scratches a person[11] |
|
Gram-negative bacteria. facultative intracellular parasites | ||
Viral | Chickenpox | − |
|
|
Whole infected cell (wc) ELISA for IgG. | − |
Coxsackie A virus | − | Children attending day care[13] | Painful blisters in the mouth, palms and on the feet.
Rash, appears after episode of high fever. |
Clinically diagnosed | − | |
Others | Primary lung cancer | − | Age >65 |
|
CT guided bronchoscopy + for malignant cells | − |
Differentiating Aspergillosis in immunocompromised host
Aspergillosis is more common among immunocompromised patients who are at high risk for other fungal, bacterial, and viral infections. It should be differentiated from the following diseases:
Disease | Differentiating signs and symptoms | Differentiating tests |
---|---|---|
CNS lymphoma[14] |
|
|
Disseminated tuberculosis[15] |
|
|
Aspergillosis[16] |
|
|
Cryptococcosis |
|
|
Chagas disease[17] |
|
|
CMV infection[18] |
|
|
HSV infection[19] |
|
|
Varicella Zoster infection[20] |
|
|
Brain abscess[21][22] |
|
|
Progressive multifocal leukoencephalopathy[23] |
|
Differentiating invasive aspergillosis from other diseases
Invasive aspergillosis must be differentiated from other conditions with similar presentation. Invasive fungal disease should be considered in any immunocompromised patient presenting with a new cranial neuropathy or ocular motility abnormality[24] for example, mucormycosis. The differentials include:
Disease | General features | Signs and Symptoms | Radiological abnormalities | Histopathological abnormalities | Other differentiating characters | ||
---|---|---|---|---|---|---|---|
Facial/Sinus swelling and ulceration | Cranial neuropathy | Disturbance in ocular motility | |||||
Mucormycosis |
|
(Mucosal thickening on the paranasal sinuses is more common in rhinocerebral mucormycosis(ROCM) than bacterial orbital cellulitis(BOC)[25] |
(Specially if there is invasion of the cavernous sinus) |
(Limited eye movement is more common in patients with rhino-cerebral mucormycosis (ROCM) than in those with bacterial orbital cellulitis)[26] |
|
|
|
Invasive aspergillosis |
|
|
|
(There may be painful ophthalmoplegia if there is invasion of the cavernous sinus)[30] |
|
|
|
Orbital cellulitis |
|
|
|
(The ocular symptoms of bacterial orbital cellulitis (BOC) , such as facial edema, pain, and blepharoptosis, are similar to those of rhino-cerebral mucormycosis (ROCM) soon after infection onset, therefore it maybe difficult to distinguish the two during the initial phase of infection. |
|
|
|
Extra nodal T cell lymphoma |
|
|
(Primary CNS NK/Tcell lymphoma of the nasal type) |
|
|
|
|
Cutaneous Anthrax |
|
|
|
|
References
- ↑ Information for Healthcare Professionals about Histoplasmosis. Centers for Disease Control and Prevention. 2015. Available at: http://www.cdc.gov/fungal/diseases/histoplasmosis/health-professionals.html. Accessed February 2, 2016.
- ↑ Brown J, Benedict K, Park BJ, Thompson GR (2013). "Coccidioidomycosis: epidemiology". Clin Epidemiol. 5: 185–97. doi:10.2147/CLEP.S34434. PMC 3702223. PMID 23843703.
- ↑ Marques SA (2013). "Paracoccidioidomycosis: epidemiological, clinical, diagnostic and treatment up-dating". An Bras Dermatol. 88 (5): 700–11. doi:10.1590/abd1806-4841.20132463. PMC 3798345. PMID 24173174.
- ↑ Mahajan VK (2014). "Sporotrichosis: an overview and therapeutic options". Dermatol Res Pract. 2014: 272376. doi:10.1155/2014/272376. PMC 4295339. PMID 25614735.
- ↑ Sherif R, Segal BH (2010). "Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications". Curr Opin Pulm Med. 16 (3): 242–50. doi:10.1097/MCP.0b013e328337d6de. PMC 3326383. PMID 20375786.
- ↑ Hicks CW, Sweeney DA, Cui X, Li Y, Eichacker PQ (2012). "An overview of anthrax infection including the recently identified form of disease in injection drug users". Intensive Care Med. 38 (7): 1092–104. doi:10.1007/s00134-012-2541-0. PMC 3523299. PMID 22527064.
- ↑ Schuetz P, Haubitz S, Christ-Crain M, Albrich WC, Zimmerli W, Mueller B (2013). "Hyponatremia and anti-diuretic hormone in Legionnaires' disease". BMC Infect. Dis. 13: 585. doi:10.1186/1471-2334-13-585. PMC 3880094. PMID 24330484.
- ↑ Lamont RF, Sobel J, Mazaki-Tovi S, Kusanovic JP, Vaisbuch E, Kim SK, Uldbjerg N, Romero R (2011). "Listeriosis in human pregnancy: a systematic review". J Perinat Med. 39 (3): 227–36. doi:10.1515/JPM.2011.035. PMC 3593057. PMID 21517700.
- ↑ Zhou YH, Xia FQ, Van Poucke S, Zheng MH (2016). "Successful Treatment of Scrub Typhus-Associated Hemophagocytic Lymphohistiocytosis With Chloramphenicol: Report of 3 Pediatric Cases and Literature Review". Medicine (Baltimore). 95 (8): e2928. doi:10.1097/MD.0000000000002928. PMC 4779037. PMID 26937940.
- ↑ Iroh Tam PY, Obaro SK, Storch G (2016). "Challenges in the Etiology and Diagnosis of Acute Febrile Illness in Children in Low- and Middle-Income Countries". J Pediatric Infect Dis Soc. 5 (2): 190–205. doi:10.1093/jpids/piw016. PMID 27059657.
- ↑ Gouriet F, Lepidi H, Habib G, Collart F, Raoult D (2007). "From cat scratch disease to endocarditis, the possible natural history of Bartonella henselae infection". BMC Infect. Dis. 7: 30. doi:10.1186/1471-2334-7-30. PMC 1868026. PMID 17442105.
- ↑ De Paschale M, Clerici P (2016). "Microbiology laboratory and the management of mother-child varicella-zoster virus infection". World J Virol. 5 (3): 97–124. doi:10.5501/wjv.v5.i3.97. PMC 4981827. PMID 27563537.
- ↑ Flett K, Youngster I, Huang J, McAdam A, Sandora TJ, Rennick M, Smole S, Rogers SL, Nix WA, Oberste MS, Gellis S, Ahmed AA (2012). "Hand, foot, and mouth disease caused by coxsackievirus a6". Emerging Infect. Dis. 18 (10): 1702–4. doi:10.3201/eid1810.120813. PMC 3471644. PMID 23017893.
- ↑ Gerstner ER, Batchelor TT (2010). "Primary central nervous system lymphoma". Arch. Neurol. 67 (3): 291–7. doi:10.1001/archneurol.2010.3. PMID 20212226.
- ↑ von Reyn CF, Kimambo S, Mtei L, Arbeit RD, Maro I, Bakari M, Matee M, Lahey T, Adams LV, Black W, Mackenzie T, Lyimo J, Tvaroha S, Waddell R, Kreiswirth B, Horsburgh CR, Pallangyo K (2011). "Disseminated tuberculosis in human immunodeficiency virus infection: ineffective immunity, polyclonal disease and high mortality". Int. J. Tuberc. Lung Dis. 15 (8): 1087–92. doi:10.5588/ijtld.10.0517. PMID 21740673.
- ↑ Latgé JP (1999). "Aspergillus fumigatus and aspergillosis". Clin. Microbiol. Rev. 12 (2): 310–50. PMC 88920. PMID 10194462.
- ↑ Rassi A, Rassi A, Marin-Neto JA (2010). "Chagas disease". Lancet. 375 (9723): 1388–402. doi:10.1016/S0140-6736(10)60061-X. PMID 20399979.
- ↑ Emery VC (2001). "Investigation of CMV disease in immunocompromised patients". J. Clin. Pathol. 54 (2): 84–8. PMC 1731357. PMID 11215290.
- ↑ Bustamante CI, Wade JC (1991). "Herpes simplex virus infection in the immunocompromised cancer patient". J. Clin. Oncol. 9 (10): 1903–15. doi:10.1200/JCO.1991.9.10.1903. PMID 1919640.
- ↑ Hambleton S (2005). "Chickenpox". Curr. Opin. Infect. Dis. 18 (3): 235–40. PMID 15864101.
- ↑ Alvis Miranda H, Castellar-Leones SM, Elzain MA, Moscote-Salazar LR (2013). "Brain abscess: Current management". J Neurosci Rural Pract. 4 (Suppl 1): S67–81. doi:10.4103/0976-3147.116472. PMC 3808066. PMID 24174804.
- ↑ Patel K, Clifford DB (2014). "Bacterial brain abscess". Neurohospitalist. 4 (4): 196–204. doi:10.1177/1941874414540684. PMC 4212419. PMID 25360205.
- ↑ Tan CS, Koralnik IJ (2010). "Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis". Lancet Neurol. 9 (4): 425–37. doi:10.1016/S1474-4422(10)70040-5. PMC 2880524. PMID 20298966.
- ↑ Trief D, Gray ST, Jakobiec FA, Durand ML, Fay A, Freitag SK, Lee NG, Lefebvre DR, Holbrook E, Bleier B, Sadow P, Rashid A, Chhabra N, Yoon MK (2016). "Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus". Br J Ophthalmol. 100 (2): 184–8. doi:10.1136/bjophthalmol-2015-306945. PMID 26112869.
- ↑ Son JH, Lim HB, Lee SH, Yang JW, Lee SB (2016). "Early Differential Diagnosis of Rhino-Orbito-Cerebral Mucormycosis and Bacterial Orbital Cellulitis: Based on Computed Tomography Findings". PLoS ONE. 11 (8): e0160897. doi:10.1371/journal.pone.0160897. PMC 4976984. PMID 27501044.
- ↑ Son JH, Lim HB, Lee SH, Yang JW, Lee SB (2016). "Early Differential Diagnosis of Rhino-Orbito-Cerebral Mucormycosis and Bacterial Orbital Cellulitis: Based on Computed Tomography Findings". PLoS ONE. 11 (8): e0160897. doi:10.1371/journal.pone.0160897. PMC 4976984. PMID 27501044.
- ↑ Guarner J, Brandt ME (2011). "Histopathologic diagnosis of fungal infections in the 21st century". Clin. Microbiol. Rev. 24 (2): 247–80. doi:10.1128/CMR.00053-10. PMC 3122495. PMID 21482725.
- ↑ Trief D, Gray ST, Jakobiec FA, Durand ML, Fay A, Freitag SK, Lee NG, Lefebvre DR, Holbrook E, Bleier B, Sadow P, Rashid A, Chhabra N, Yoon MK (2016). "Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus". Br J Ophthalmol. 100 (2): 184–8. doi:10.1136/bjophthalmol-2015-306945. PMID 26112869.
- ↑ Hamilos G, Samonis G, Kontoyiannis DP (2011). "Pulmonary mucormycosis". Semin Respir Crit Care Med. 32 (6): 693–702. doi:10.1055/s-0031-1295717. PMID 22167397.
- ↑ Siraj CA, Krishnan J, Nair RR, Girija AS (2005). "Invasive aspergillosis producing painful ophthalmoplegia". J Assoc Physicians India. 53: 901–2. PMID 16459537.
- ↑ Jung J, Kim MY, Lee HJ, Park YS, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH (2015). "Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis". Clin. Microbiol. Infect. 21 (7): 684.e11–8. doi:10.1016/j.cmi.2015.03.019. PMID 25882362.
- ↑ Chaudhry IA, Al-Rashed W, Arat YO (2012). "The hot orbit: orbital cellulitis". Middle East Afr J Ophthalmol. 19 (1): 34–42. doi:10.4103/0974-9233.92114. PMC 3277022. PMID 22346113.
- ↑ Son JH, Lim HB, Lee SH, Yang JW, Lee SB (2016). "Early Differential Diagnosis of Rhino-Orbito-Cerebral Mucormycosis and Bacterial Orbital Cellulitis: Based on Computed Tomography Findings". PLoS ONE. 11 (8): e0160897. doi:10.1371/journal.pone.0160897. PMC 4976984. PMID 27501044.
- ↑ Zhang Y, Wang T, Liu GL, Li J, Gao SQ, Wan L (2016). "Mucormycosis or extranodal natural killer/T cell lymphoma, similar symptoms but different diagnosis". J Mycol Med. 26 (3): 277–82. doi:10.1016/j.mycmed.2016.04.005. PMID 27178138.
- ↑ Prajapati HJ, Vincentelli C, Hwang SN, Voloschin A, Crocker I, Dehkharghani S (2014). "Primary CNS natural killer/T-cell lymphoma of the nasal type presenting in a woman: case report and review of the literature". J. Clin. Oncol. 32 (8): e26–9. doi:10.1200/JCO.2012.47.6796. PMID 24419127.
- ↑ Mallon E, McKee PH (1997). "Extraordinary case report: cutaneous anthrax". Am J Dermatopathol. 19 (1): 79–82. PMID 9056659.
- ↑ Skiada A, Petrikkos G (2013). "Cutaneous mucormycosis". Skinmed. 11 (3): 155–9, quiz 159–60. PMID 23930354.